Pure Global
NCT06415812

Evolutionary Systems Therapy for Personality Pathology

Evolutionary Systems Therapy for Early Onset of Personality Pathology: A Pilot Study on the Effectiveness and Feasibility With Adolescents and Young Adults
Tages Onlus·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Personality Disorders
Drug/Device/Intervention
Evolutionary Systems Therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Tages Onlus
Location
Firenze, Italy
Timeline & enrollment
Phase
N/A
Start date
Oct 02, 2023
End date
Sep 01, 2024
Enrollment
21 participants
Primary outcome

Rate of individual change in personality pathology over time,Group change in personality pathology over time,Feasibility of the intervention

Summary

Evolutionary Systems Therapy is a new form of therapy that has been previously tested in a
 randomized controlled trial and in a few cases of patients diagnosed with Cluster A
 personality disorders. The objective of the present study is to investigate the feasibility
 and preliminary efficacy of Evolutionary Systems Therapy in all forms of personality
 disorders. The study includes three project actions: (i) a case series on adolescents with
 personality disorders; (ii) a case series on young adults with personality disorders; (iii)
 an ecological momentary assessment study to confirm the conceptualization model on all the
 patients.

ICD-10 classifications
Specific personality disordersOther specific personality disordersPersonality disorder, unspecifiedDisorders of adult personality and behaviourOther specified disorders of adult personality and behaviour
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06415812
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06415812 through Pure Global AI's free database. This phase not specified trial is sponsored by Tages Onlus and is currently Recruiting. The study focuses on Personality Disorders. Target enrollment is 21 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.